Drug Development Based on 3Dmicroflu™

CD BioSciences is a cutting-edge biotechnology company committed to providing 3D bioprinted tissue and organ micro-models. With a team of experienced experts and a unique 3D printing technology platform called 3Dmicroflu™, we can provide you with relevant research services covering various life science fields. One of the very important applications of 3Dmicroflu™ technology platform for printing tissue and organ micro-models is drug development. Micro-models of organs, tissues and diseases are important tools when studying them in vitro in drug development. 3Dmicroflu™ technology platform can provide guidance and assistance in processes such as toxicology studies and drug screening.

Overview of drug development

There are four important processes in the drug development phase, including target identification, model building, lead compound discovery, and lead compound optimization. How to advance the process of drug development is a long-standing problem for researchers to solve. This is because the sooner new drugs of applicability are available, the sooner the suffering of people with diseases will be cured. This is the goal that researchers working on drug development have been striving to achieve. From basic research to successful clinical trials and finally to the launch of a finished drug, it is necessarily a long process. But for the safety of the drug and the health of life, such a long time is worth the wait.

Drug Development Based on 3Dmicroflu™

However, the entire development process can be advanced by accelerating a process in drug development or by improving research tools. The ability to simulate human organs, tissues or drug models in real physiological states plays an important role in drug development. In general, traditional models are 2D cellular models as well as animal models, which necessarily do not adequately reflect human characteristics. This can lead to a wide variability in the effects of drugs, such as in vitro experiments with good efficacy but no effect in the clinical setting. Here, at CD BioSciences, we can provide you with services to build various types of 3D biological models including micro-organs, micro-tissues, micro-systems, various disease models, etc. These in vitro micro-models can be used in the drug discovery process and are based on our high resolution 3D printing 3Dmicroflu™ technology platform.

3Dmicroflu™ for the applications of drug development

CD BioSciences can provide you with high-resolution single-cell printing services based on 3Dmicroflu™ technology platform that are ideal for detailed and complex model construction. 3Dmicroflu™ technology platform can facilitate the entire drug development process by accelerating experiments related to model construction such as drug mechanism of action studies and drug screening. Moreover, using our technology platform to construct physiologically appropriate biological models for drug discovery will significantly reduce unnecessary time and cost wastage.

Drug Development Based on 3Dmicroflu™

Drug Action Mechanism Research

Drug mechanism of action research focuses on two main areas, including pharmacokinetic research and pharmacodynamic research. Pharmacokinetics focuses on the effect of the body on the drug, while pharmacodynamics focuses on the effect of the drug on the body. CD BioSciences can provide 3Dmicroflu™-based micro-model construction services for drug tolerance analysis, drug efficacy and safety evaluation, toxicity testing, active ingredient screening, etc. By choosing 3Dmicroflu™ technology platform, the process of studying the mechanism of action of these drugs will be greatly facilitated.

Drug Development Based on 3Dmicroflu™

High Throughput Drug Screening

important ways to advance drug discovery. In vitro disease models are an important tool in the drug screening process. The gap between traditional animal models and real human disease states is still too large and often produces invalid screening results. Here, CD BioSciences can provide you with 3D micro-models that truly reflect the physiological characteristics of the disease and better facilitate the drug screening process. 3Dmicroflu™ technology platform can advance the entire drug discovery process by accelerating drug screening.

Drug mechanism of action studies and drug screening are important components of drug discovery centers and determine the progress of drug development. 3Dmicroflu™ technology platform can provide micro-model 3D printing customization service for these processes, which can greatly improve the efficiency of drug development process and the acquisition of effective data.

If you are interested in 3Dmicroflu™ technology platform involved in drug development, please feel free to contact us for customization services. We always hope that our technology platform will be of great help and provide guidance to your R&D process. All services from CD BioSciences are available on a 24/7/365 basis.

For research use only, not intended for any clinical use.